STAT

SEPTEMBER 19, 2024

GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease , addiction , and even Alzheimer’s. Now, three scientists who played key roles in their invention have won a prestigious Lasker Award for biomedical research.  Announced on Thursday in New York, the Lasker-DeBakey Clinical Medical Research Award will be shared by Svetlana Mojsov and Joel Habener , who identified and characterized the GLP-1 hormone in the 1980s whil

Pharmaceutical Companies 362

Pharmaceutical Companies Pharmaceutical Companies Hospitals 362

The Pharmacist

SEPTEMBER 19, 2024

National Pharmacy Association (NPA) members across the UK have participated in a second day of action today by wearing black, displaying posters and raising awareness of the impact of funding cuts on the sector. It comes as the NPA has announced plans to escalate its action and ballot its members on 'working to rule'. Gordons […] The post Protest action hoped to spotlight pharmacy plight appeared first on The Pharmacist.

122

122

STAT

SEPTEMBER 19, 2024

NEW YORK — Nearly two decades ago, European regulators pulled an obesity drug called rimonabant off the market due to concerns it was tied to suicidal ideation. Now, a small handful of companies are developing drugs that use a similar approach to the discarded treatment, which involves inhibiting type 1 cannabinoid receptors, or CB1 receptors.

334

334

Drug Patent Watch

SEPTEMBER 19, 2024

The generic drug market in the United States is characterized by significant price volatility and shortages, driven by the structure of the market and the incentives for manufacturers. To address these issues, several market-based proposals have been put forth to optimize generic drug cost and availability.

102

102

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

STAT

SEPTEMBER 19, 2024

On Tuesday, the Centers for Disease Control and Prevention, the Centers for Medicare and Medicaid Services, and the Agency for Healthcare Research and Quality took an important step: They launched the Core Elements of Hospital Diagnostic Excellence , a new project to help reduce the number of Americans who die or are permanently disabled each year by diagnostic error.

Hospitals 328

Hospitals 328

Express Pharma

SEPTEMBER 19, 2024

Laurus Labs an R&D-driven pharmaceutical and biotech company in India has inaugurated a new R&D center at IKP Knowledge Park, Plot No DS15, Kolthur Shamirpet Medchal, Telangana. The new facility was inaugurated by Duddilla Sridhar Babu Garu, Minister of Information Technology, Electronics and Communications, Industries and Commerce, and Legislative Affairs – Government of Telangana along with Dr Satyanarayana Chava, Founder and CEO Laurus Labs along with other senior management team m

Communication 102

Communication 102

Express Pharma

SEPTEMBER 19, 2024

Piramal Pharma has embarked on its sustainability journey as the Science Based Targets initiative (SBTi) officially validated the company’s near-term greenhouse gas (GHG) emission reduction targets. Piramal has committed to reducing absolute scope 1 and 2 GHG emissions by 42 per cent by FY2030 from an FY2022 base year. It has also committed to reducing absolute scope 3 GHG emissions from purchased goods and services, fuel and energy-related activities, upstream transportation and distribution,

Pharmaceutical Companies 101

Pharmaceutical Companies Pharmaceutical Companies 101

STAT

SEPTEMBER 19, 2024

A group of lawmakers wants the U.S. Patent & Trademark Office and drug companies to change their approach toward handling mistakes in disclosing patent terms, because the errors can be exploited in ways that thwart competition and, ultimately, raise the cost of medicines. The problem cited by the lawmakers concerns the way that administrative delays are handled at the PTO.

Pharmaceutical Companies 285

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 285

Express Pharma

SEPTEMBER 19, 2024

Fermenta Biotech’s Active Pharmaceutical Ingredient (API) manufacturing facility situated in Dahej, Gujarat, has received a certificate of GMP compliance from the Competent Authority of Germany, following a European Union Good Manufacturing Practice (EU GMP) inspection that was conducted in March 2024. This approval reflects that the company’s quality assurance complies with the guidelines of Good Manufacturing Practices.

98

98

STAT

SEPTEMBER 19, 2024

Amid ongoing concern over the quality of medicines made in India, a major supplier of generic medicines was seen removing three truckloads of “scrap materials” from a facility that was being inspected last month by the Food and Drug Administration. Specifically, a “large number of torn pieces” of documents that should have been kept to verify manufacturing and testing practices were found in the trucks, as well as in a scrap bag at a site run by Granules in Telangana,

Documentation 280

Documentation Generic Medicine 280

Speaker: Joe Sharpe and James Carlson

In the world of small business management, the challenge of managing payroll & HR efficiently while scaling operations can be overwhelming. Yet, with the right strategies in place, these challenges can become opportunities for growth and innovation. In this session, Joe Sharpe, Senior Director of Managed Payroll Services at IRIS, will reveal practical methods and expert insights for outsourcing and streamlining payroll processes, resulting in substantial time and resource savings.

pharmaphorum

SEPTEMBER 19, 2024

Explore how the pharmaceutical industry is ensuring supply chain resilience to maintain consistency despite global events. Learn more about strategies and practices implemented to address challenges and ensure reliable delivery of pharmaceutical products.

97

97

STAT

SEPTEMBER 19, 2024

Are generalist investors good or bad for biotech? How did Elaine and Adam’s trip to New York go? And how long has George Church owned that brown corduroy blazer? We cover all that and more on the latest episode of “The Readout Loud.” Mizuho analyst Jared Holz joins us to discuss what the Federal Reserve’s long-awaited decision to lower interest rates means for biotech stocks and startups.

270

270

BioPharma Dive

SEPTEMBER 19, 2024

According to the company, the results are the first time an antiviral drug has reduced transmission of a respiratory virus in a global Phase 3 trial.

104

104

STAT

SEPTEMBER 19, 2024

Serial biotech founder George Church has a new startup, and this time, he has skin in the game, quite literally.  Church, the enigmatic founder behind companies including eGenesis , Editas Medicine, and Colossal Biosciences , donated some of his own skin cells for use at his new startup GC Therapeutics. (And yes, the letters in the company’s name stand for “George Church.

Immunity 239

Immunity Immunization 239

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Express Pharma

SEPTEMBER 19, 2024

The Union Cabinet, chaired by Prime Minister Narendra Modi, approved the continuation of the two umbrella schemes of the Department of Biotechnology (DBT), merged as one scheme – ‘Biotechnology Research Innovation and Entrepreneurship Development (Bio-RIDE)’ with a new component namely Biomanufacturing and Biofoundry. The scheme has three broad components: Biotechnology Research and Development (R&D); Industrial & Entrepreneurship Development (I&ED) Biomanufacturing and Biofoun

90

90

STAT

SEPTEMBER 19, 2024

In June, a clinical trial showed that a twice-yearly injection was just as effective at preventing HIV as the daily oral medication. The trial  was so successful  that the Data Monitoring Committee instructed researchers to halt the study and immediately offer the injection to all study participants.  This is just the most recent development in longer-acting HIV medications, which have become a transformative force in the journey toward ending the HIV/AIDS crisis.

239

239

PharmaVoice

SEPTEMBER 19, 2024

The disparate teams of research and commercial at J&J work closely together from the get-go.

100

100

STAT

SEPTEMBER 19, 2024

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Talkspace offers therapy through Amazon now As virtual mental health company Talkspace aims to grow its business, it’s added a very large entry point to the top of its funnel.

Diabetes 232

Diabetes 232

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Express Pharma

SEPTEMBER 19, 2024

Atopic dermatitis (AD) is emerging as a dynamic field ripe with innovation and investment opportunities. With the market projected to reach $16.7 billion by 2030 across the seven major markets (7MM*), driven by rising prevalence and advancements in treatment, pharmaceutical companies are increasingly focusing on novel therapies. This sector promises substantial growth as new treatments address unmet needs and reshape patient care, says GlobalData.

Pharmaceutical Companies 87

Pharmaceutical Companies Pharmaceutical Companies Communication 87

STAT

SEPTEMBER 19, 2024

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. I’ve been in New York City all week attending the Cantor Global Healthcare Conference and meeting with investor sources. Big thanks to Cantor hosts Josh Schimmer and Eric Schmidt for the invite.

229

229

pharmaphorum

SEPTEMBER 19, 2024

Neuralink gets FDA breakthrough status for an implantable chip called Blindsight that promises to restore eyesight to the blind

103

103

STAT

SEPTEMBER 19, 2024

Check out STAT’s exclusive breakthrough devices tracker.  The latest medical devices to receive breakthrough status from the Food and Drug Administration range across conditions, with several treating cardio and neurovascular conditions.  The FDA’s breakthrough devices program is designed to speed the path to market for novel, potentially lifesaving products.

232

232

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

BioPharma Dive

SEPTEMBER 19, 2024

Industry insiders hope the Fed’s decision to cut rates for the first time in years will boost biotech investment. But the long-awaited move won’t cure all that ails the sector, others cautioned.

75

75

STAT

SEPTEMBER 19, 2024

Rise and shine, everyone, another busy day is on the way. However, this is shaping up as a beautiful day as well, despite forecasts suggesting a cloud or two will later hover about. Right now, the skies are tranquil, birds are chirping, and the official mascots are hunting for snacks on the Pharmalot campus. This calls for celebration with a cup of stimulation, and we are reaching for maple bourbon, a reliable stand-by.

Compounding 179

Compounding Compounding Pharmacies Packaging 179

pharmaphorum

SEPTEMBER 19, 2024

Upstream Bio has become the latest biotech to chance its arm with a public listing in the US, seeking funds for its rival to respiratory drug Tezspire.

80

80

STAT

SEPTEMBER 19, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. Some news from Washington from late yesterday: Lawmakers advanced legislation that would extend a program to aid the development of drugs for rare diseases in children.

Drug Pricing 164

Drug Pricing Drug Development 164

pharmaphorum

SEPTEMBER 19, 2024

Daiichi Sankyo's FLT3 inhibitor Vanflyta has been recommended for NHS use as a treatment for a specific form of acute myeloid leukaemia (AML) in England and Wales, the first countries in Europe to authorise use of the drug after a health technology assessment (HTA) review.

77

77

STAT

SEPTEMBER 19, 2024

A Senate committee on Thursday approved referring Steward Health Care chief executive Ralph de la Torre for civil and criminal charges over his refusal to testify about the hospital chain’s financial crisis. The Senate Health, Education, Labor, and Pensions Committee voted 20 to zero, with only Kentucky Senator Rand Paul abstaining, on both resolutions to hold de la Torre in contempt of Congress after  he skipped appearing at a hearing last week  despite being subpoenaed.

Hospitals 138

Hospitals 138

Express Pharma

SEPTEMBER 19, 2024

Following a successful edition in 2023, analytica Anacon India and India Lab Expo along with Pharma Pro&Pack Expo are set to make their mark in Hyderabad, the pharma hub of India, from September 26-28. This year’s event will be the largest edition to date, featuring over 500+ technology suppliers from 14+ countries. The triad event aims to create a transformative experience for the pharmaceutical, analytical, biotechnology, and R&D sectors.

Packaging 66

Packaging Documentation 66

BioPharma Dive

SEPTEMBER 19, 2024

GC Therapeutics claims it can create off-the-shelf therapies from induced pluripotent stem cells faster than by current methods with a simpler process.

72

72

Express Pharma

SEPTEMBER 19, 2024

Eppendorf India and Rajalakshmi Engineering College, Chennai have signed the extension of the existing Memorandum of Understanding (MoU) in setting up a framework to enable mutually beneficial and collaborative engagements in training to improve scientific research and development in the field of Biotechnology. Eppendorf is committed to skill development by offering tailor-made training programs for graduate students of Biotechnology.

66

66

The Pharmacist

SEPTEMBER 19, 2024

Community Pharmacy England (CPE) has suggested that the outcome of the National Pharmacy Association (NPA)'s ballot could inform considerations around its own negotiating tactics and positioning. Pharmacy sector leaders have today joined the NPA to deliver a petition to Downing Street and to voice concerns about pharmacy funding, following the membership organisation's announcement that it […] The post Negotiator 'interested' to hear outcome of NPA ballot appeared first on The Ph

Community Pharmacies 62

Community Pharmacies 62